January 2019



  • GREETINGS from Dr. Dietmar Thumm


  • No efficacy proven for Lampalizumab in geographic atrophy
  • Do Patients with Retinal Artery Occlusion Need Urgent Neurologic Evaluation?
  • Factors Associated with Graft Rejection in the Cornea Preservation Time Study
  • The effect of cold tetracaine on the severity of burning sensation upon instillation

pdf  Newsletter January 19



November 2018



  • GREETINGS from Dr. Theo Signer


  • n−3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease- no effect proven
  • Aflibercept and nAMD - Does a lot help a lot?
  • Are risk factors for growth of choroidal nevi associated with malignant transformation?
  • Posterior capsular complication rates with femtosecond laser-as- sisted cataract surgery: a consecutive comparative cohort and literature review
  • Antivascular endothelial growth factor agents pretreatment before vitrectomy for complicated proliferative diabetic retino- pathy: a meta-analysis of randomized controlled trials
  • Aerpio completes enrolment in Phase IIb trial of AKB-9778 for Diabetic Retinopathy
  • New analysis of Novartis Phase III brolucizumab (RTH258) data in nAMD
  • Sub-Threshold Nanosecond Laser Intervention in Age-Related Macular Degeneration: The LEAD Randomized Controlled Clini- cal Trial

Full version as pdf  Newsletter November 18



August 2018



  • Greetings from the President


  • Conservatively Treated Orbital Blowout Fractures - Spontaneous Radiologic Improvement
  • The XEN45 Gel Stent as a minimally invasive procedure in glaucoma surgery
  • Epithelium-on photorefractive intrastromal cross-linking (PiXL) for reduction of low myopia
  • Efficacy and Safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy in the PLANET Study
  • Evaluation of the Macular Ganglion Cell-Inner Plexiform Layer and the Circumpapillary Retinal Nerve Fiber Layer in Early to Severe Stages of Glaucoma: Correlation with Central Visual Function and Visual Field Indexes
  • Real-World Vision in Age-Related Macular Degeneration Patients Treated with Single Anti-VEGF Drug Type for 1 Year in the IRIS Registry
  • Real-life clinical data for dexamethasone and ranibizumab in the treatment of branch or central retinal vein occlusion over a period of six months
  • Additive effects of orthokeratology and atropine 0.01% ophthalmic solution in slowing axial elongation in children with myopia: first year results

Download as pdf  Newsletter August 18



April 2018



  • Looking Back: SAoO Congress 28.2. – 2.3.2018
  • Innovation Prize: Marc Gobin


  • Antiplatelet and Anticoagulant Drugs Do Not Affect Visual Outcome in Neovascular Age-Related Macular Degeneration in the BRAMD Trial.
  • Early Versus Late Canalicular Laceration Repair Outcomes
  • Comparative analysis of the safety and efficacy of intracameral cefuroxime, moxifloxacin and vancomycin at the end of cataract surgery: a meta-analysis.
  • Recent clinically relevant highlights from the Diabetic Retinopathy Clinical Research Network
  • Circulating Serum Fatty Acid-Binding Protein 4 ( FABP4) Levels Predict the Development of Diabetic Retinopathy in Type 2 Diabetic Patients.
  • Smartphones in ophthalmology

Download as PDF Newsletter April 2018



January 2018



  • Editorial
  • 2ⁿd SAoO convention February 28 – March 2, 2018
  • Congress Specials
  • First General Assembly of the Swiss Academy Association


  • Status of Selective Laser Trabeculoplasty (SLT)
  • A genetic Revolution for Ophthalmology?
  • AAO 2017 Retina Subspecialty Day: Protocol U
  • Acute Central Serous Chorioretinopathy – Factors Influencing Episode Duration
  • Topical treatment for keratoconus gains orphan status
  • The ISNT Rule: How Often Does It Apply to Disc Photographs and Retinal Nerve Fiber Layer Measurements in the Normal Population?
  • Comparison of Glaucoma Progression Detection by Optical Coherence Tomography and Visual Field

Download as PDF Newsletter January 2018